Table 3 Number of AEs or laboratory abnormalities by grade and group in the erythrocytic phase: after initiation of treatment of malaria or day 21 until the end of follow up visits on day 90

Severity grade

Challenge group

Total

(n = 6 for each group)

Group 1

2,500 PfSPZ 10 µL × 2 IM

Group 2

2,500 PfSPZ 50 µL × 2 IM

Group 3

2,500 PfSPZ 250 µL × 2 IM

Group 4

3,200 PfSPZ 500 µL × 1 DVI

Group 5

25,000 PfSPZ 10 µL × 2 IM

Group 6

75,000 PfSPZ 10 µL × 2 IM